Patent · US Expired

FAS ligand fusion proteins and their uses

US6046310A · kind A · utility

30Cited by
3References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 1997
Grant dateApr 4, 2000
Priority date
Expiry dateMar 11, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Fas ligand fusion proteins comprising a polypeptide capable of specifically binding an antigen or a cell surface marker are prepared employing recombinant DNA technology for use in, e.g., treatment of autoimmune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.